Vetr Crowd Upgrades Valeant

Loading...
Loading...

The Vetr community has upgraded Valeant Pharmaceuticals Intl Inc VRX from 3 stars to 3.5 stars.

The crowd is overall much more bearish on the name than Wall Street, with a price target of $14.26 compared to analyst consensus $24.58.

See how crowdsourced ratings can help predict the market?

Valeant shares closed at $12.92 Monday.

For the crowd's full analysis of the stock, click here.

Posted In: UpgradesCrowdsourcingAnalyst RatingsGeneralVetr
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...